TGA Approval

ZOLGENSMA onasemnogene abeparvovec 2 x e13 vg/mL injection for intravenous infusion 8.3 mL vial (327905)

ARTG ID

327905

ARTG Name

ZOLGENSMA onasemnogene abeparvovec 2 x e13 vg/mL injection for intravenous infusion 8.3 mL vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

March 4, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/898911bfb53dd716bb4a79f5cf8c3232.pdf

https://medical-cdn.nocode.com/drug_tga/e0b112ac040918c266be557ff4a7bead.pdf

Ingredient Name

onasemnogene abeparvovec

Empowering clinical research with data-driven insights and AI-powered tools.

ZOLGENSMA onasemnogene abeparvovec 2 x e13 vg/mL injection for intravenous infusion 8.3 mL vial (327905) - TGA 批准文号 | MedPath